Key facts
- Notable investors include Meridian Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Tyle
- ·The full record, as it builds
Funding rounds
No funding rounds for Tyle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tyle
Developer of AI powered skin imaging technology designed to support early detection of skin conditions and improve preventative dermatological care. The company combines no contact full body imaging, continuous AI analysis, and dermatologist oversight to detect early signs of skin cancer, aging, and other conditions, track subtle changes over time, and rapidly assess specific moles or spots, it securely maps users skin profiles and delivering clear, physician reviewed reports via a digital platform, enabling health conscious consumers to seek convenient, data driven skin monitoring and enhance skin health.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 3
- Website
- jointyle.com/
- Ownership
- Privately Held (backing)
Tyle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tyle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tyle in its N-PORT filings yet. We sweep new filings monthly.